about
Posttranslational modifications in connexins and pannexinsRegulation of the proteasome by ATP: implications for ischemic myocardial injury and donor heart preservationExercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failureMolecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up.Phosphoprotein abundance changes in hypertensive cardiac remodeling.Pregnancy is associated with decreased cardiac proteasome activity and oxidative stress in mice.Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability.Bortezomib, a proteasome inhibitor, attenuates angiotensin II-induced hypertension and aortic remodeling in rats.Proteasome malfunction activates macroautophagy in the heart.Proteasome functional insufficiency in cardiac pathogenesis.Substrate Ubiquitination Controls the Unfolding Ability of the Proteasome.Cardiac systolic dysfunction in doxorubicin-challenged rats is associated with upregulation of MuRF2 and MuRF3 E3 ligasesSodium Sulfide Attenuates Ischemic-Induced Heart Failure by Enhancing Proteasomal Function in an Nrf2-Dependent Manner.Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failureThe endoplasmic reticulum in cardiovascular health and disease.A practical review on carfilzomib in multiple myeloma.A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma.Safety issues and management of toxicities associated with new treatments for multiple myeloma.Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib.Diclofenac induces proteasome and mitochondrial dysfunction in murine cardiomyocytes and hearts.Sodium 4-Phenylbutyrate Attenuates Myocardial Reperfusion Injury by Reducing the Unfolded Protein Response.Carfilzomib for treating myelomaEmergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy
P2860
Q26825229-474FEE5F-6362-4685-9333-1BF3C9D946DFQ27000202-9266633E-9BB8-4199-AA70-76422E1EFDC6Q28481996-E11F122E-2F44-4A99-B03F-96BB897EE168Q33578496-F453BB88-2272-4400-A992-0CFA9B4C07C9Q34289975-44B11CBC-E9A6-400D-91DA-D10C6599F110Q34481968-5B779FFD-2653-42E6-B517-8BE7A65FBB4BQ34893956-E1571B3E-9A4B-4166-92CB-A1CF4303516BQ35036537-A510A40D-08A7-49E2-9DFC-574D4C8AEF2EQ35536300-13D06C5C-B82C-4D58-A61E-C58BD0A38C18Q35601400-021D4F31-0D98-44DC-8BC3-6B91329E137BQ36074198-FA92BB67-86F3-4B94-9AA2-D8FB8EE8CB53Q36772298-A17C51FD-CC46-4258-9F70-4FD3B8FD4961Q36784081-0F222E62-576A-4E1C-A336-545DC6218F96Q37476517-48F21C26-8871-470A-9AE4-752563F9363DQ38034992-F1008874-F8BB-47CE-884D-82905A80B4EDQ38740271-37A62611-8A11-4834-B5E6-CC6CDBE314F7Q38807562-16B4BAEA-8D6E-45EC-898C-109DD539DB6BQ39100317-0AFC1C45-CDFF-49A2-9E1E-4636117B4C9CQ43127820-80EC7EF0-C7DB-4F16-B96C-F6D2FD5D2C1FQ46055251-4084D1E8-B832-4AFC-A78B-9769BE1BC806Q48409756-C2D6A34D-82D9-4115-AD94-1EC849188C57Q57904173-52526473-EA00-49B1-8F87-B5E4E19C2790Q58728912-4DCF3B6B-67BE-407B-A029-9972CED0326E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of the proteasome in heart disease
@en
The role of the proteasome in heart disease.
@nl
type
label
The role of the proteasome in heart disease
@en
The role of the proteasome in heart disease.
@nl
prefLabel
The role of the proteasome in heart disease
@en
The role of the proteasome in heart disease.
@nl
P2860
P1476
The role of the proteasome in heart disease
@en
P2093
P2860
P304
P356
10.1016/J.BBAGRM.2010.09.001
P407
P50
P577
2010-09-15T00:00:00Z